News

Jun. 17, 2025Press Release

Sysmex Establishes a Subsidiary in Greece

- Strengthening Sales and Customer Care Structures to Promote Business Expansion -

Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) has announced the establishment of a new subsidiary, Sysmex Greece I.K.E. Going forward, Sysmex aims to expand business in Greece by strengthening its sales and customer care structures.

Although Greece was affected by the financial crisis after 2009, its economy has been recovering in recent years. Since 2021, its real GDP has continued to grow at a pace that exceeds the overall real GDP growth of the eurozone. In addition, public medical services are widely provided under the universal health insurance system, and the healthcare market is expected to continue expanding due to the rapid aging of the population.

Since establishing a subsidiary in Germany in 1980, Sysmex has been working to strengthen its business foundation in European countries. In Greece, it has been selling its products and providing customer care via business partners and local distributors for over 30 years.

Sysmex has established a subsidiary in Greece to enhance its presence by accurately identifying its customer needs through direct communication. This has resulted in the development of its business foundation in key European countries and regions. The company will commence direct sales and customer care through the subsidiary, in addition to business conducted through existing business partner, in the fields of hemostasis, urinalysis, clinical FCM^* and life sciences with the aim of expanding its business.

By providing globally standardized, high-quality customer care and creating added value tailored to local characteristics, the company will strengthen its hemostasis and urinalysis fields while also establishing business foundations in the clinical FCM and life science fields, thereby accelerating future businesses by leveraging synergies between the company’s businesses.

Going forward, Sysmex will continue to strengthen its sales and customer care structures while promoting the unique value it offers, thereby contributing to the advancement of healthcare.

Overview of the New Subsidiary

	Name:	Sysmex Greece I.K.E.
	Location:	Athens, Greece
	Representative:	Arndt Knestel
	Established:	June 2025
	Capital:	1,000,000 EURO
	Capital supplied by:	Sysmex Europe SE
		(Sysmex Europe SE is a wholly owned subsidiary of Sysmex Corporation.)
	Employees:	10 (expected as of the end of fiscal year 2025)
	Line of business:	Sales and provision of customer care for in vitro diagnostic instruments, reagents, and laboratory information systems

Terminology

*	Clinical FCM:
	The cell measurement testing using flow cytometers in a medical field, such as clinical laboratory testing. It is used to diagnose blood diseases such as leukemia and malignant lymphoma, to monitor the immune function of HIV patients, and to consider treatment plans.

About Sysmex Corporation

Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives. For more information about Sysmex, please visit www.sysmex.co.jp/en/.
* "Healthcare journey" is a trademark of Sysmex Corporation, registered in Japan.

FOLLOW US　

Information contained in the news release is current as of the date of the announcement,
but may be subject to change without prior notice.

Back to "News"